what class of drug is tirzepatide F.D.A. Approves New Obesity That Will Compete With Wegovy Effect of tirzepatide on change

When a patient experiences severe lower abdominal pain while taking tirzepatide, temporarily discontinue the medication and evaluate for potential gastrointe...

At 50% uptake, and assuming a 15.5% discontinuation rate as observed in the SOUL trial, an estimated 59,332 MACE, 14,215 cardiovascular deaths, 41,744 nonfatal myocardial infarctions, and 12,260 nonfatal strokes could be prevented

Scientists have now created long-lasting GLP-1 drugs that can be used to treat type 2 diabetes, obesity, and a range of other conditions

Side effects are uncommon and typically limited to mild nasal irritation

In todays digital age, where internet access and social media are widespread, patients are empowered to take a more proactive role in managing their healthcare

We need to have a more balanced conversation about GLP-1 medications